Results 211 to 220 of about 272,924 (242)
Some of the next articles are maybe not open access.
Acute Coronary Syndrome and Preeclampsia
Obstetrics & Gynecology, 2005Myocardial ischemia and infarction are rare during pregnancy. Approximately 150 cases of myocardial infarction during pregnancy have been documented in the literature worldwide (predominantly anterior wall). However, elevated troponin levels have been reported in patients with preeclampsia.We describe 2 patients with preeclampsia who presented with ...
Sepideh, Nabatian +3 more
openaire +2 more sources
Primary Care: Clinics in Office Practice
One percent of primary care visits are due to chest pain. It is critical for the primary care physician to have a high index of suspicion for acute coronary syndrome and understand the management of this important condition. This article reviews the outpatient evaluation and management of chest pain and summarizes the key points of inpatient evaluation
Raman, Nohria, Brian, Antono
openaire +2 more sources
One percent of primary care visits are due to chest pain. It is critical for the primary care physician to have a high index of suspicion for acute coronary syndrome and understand the management of this important condition. This article reviews the outpatient evaluation and management of chest pain and summarizes the key points of inpatient evaluation
Raman, Nohria, Brian, Antono
openaire +2 more sources
The challenge of acute coronary syndromes
The Lancet, 1999I n t roduc t ion Acute coronary syndromes (ACS) pose multiple challenges to physicians, cardiologists, internists, and emergency department physicians, as well as to general practitioners. General practitioners are responsible for early recognition of ACS among patients with chest discomfort and identification of patients who require hospital ...
Simoons, Maarten +3 more
openaire +3 more sources
Enoxaparin in acute coronary syndromes
Expert Review of Cardiovascular Therapy, 2007Enoxaparin is a low-molecular-weight heparin (LMWH) derivative that exerts its anticoagulant activity through antithrombin III, an endogenous inhibitor of factor Xa and thrombin IIa. Unlike its unfractionated heparin (UFH) counterparts, enoxaparin has a greater bioavailability, lower incidence of heparin-induced thrombocytopenia and more stable and ...
Sinjin, Lee, C Michael, Gibson
openaire +2 more sources
Thrombosis and Acute coronary syndrome
Thrombosis Research, 2012Acute coronary syndromes (ACS) represent the main clinical manifestation of atherosclerotic progression in the coronary district. Thrombosis plays a critical role in the patho-anatomical of ACS, as disruption of an atherosclerotic plaque exposes flowing blood to subendothelial collagen, tissue factor, and other procoagulant molecules that trigger ...
ABBATE, ROSANNA +4 more
openaire +3 more sources
Anticoagulants in acute coronary syndromes
The American Journal of Cardiology, 1999Antithrombotic and antiplatelet agents, particularly unfractionated heparin and aspirin, are longstanding therapeutic mainstays for acute coronary syndromes such as unstable angina and non-Q-wave myocardial infarction (MI). Early studies demonstrated that aspirin reduces the risk of mortality or nonfatal MI by 50-70% in patients presenting with ...
openaire +2 more sources
Triggers of acute coronary syndromes
Progress in Cardiovascular Diseases, 2002Despite recent progress in prevention of coronary heart disease, approximately 50% of the deaths from coronary artery disease continue to occur out of hospital, and many major cardiac events occur in individuals not previously known to be at risk. These facts create the need to identify the acute causes of myocardial infarction (MI) and sudden death ...
Stephen J, Servoss +2 more
openaire +2 more sources
â–¼Clopidogrel and acute coronary syndrome
Drug and Therapeutics Bulletin, 2002â–¼Clopidogrel (Plavix - Sanofi-Synthelabo & Bristol-Myers Squibb) blocks platelet aggregation through an action distinct from that of aspirin. In the UK, it is licensed for the secondary prevention of atherosclerotic events and for this, we concluded 3 years ago that clopidogrel "appears to offer no worthwhile advantage over aspirin".1 After ...
openaire +2 more sources